Omnicell EBITDA Margin 2010-2023 | OMCL
Omnicell EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2023-12-31 | $1.15B | $0.07B | 5.66% |
2023-09-30 | $1.19B | $0.05B | 4.21% |
2023-06-30 | $1.24B | $0.07B | 5.34% |
2023-03-31 | $1.27B | $0.07B | 5.68% |
2022-12-31 | $1.30B | $0.10B | 7.79% |
2022-09-30 | $1.31B | $0.15B | 11.76% |
2022-06-30 | $1.26B | $0.17B | 13.21% |
2022-03-31 | $1.20B | $0.18B | 15.18% |
2021-12-31 | $1.13B | $0.20B | 17.40% |
2021-09-30 | $1.07B | $0.20B | 18.97% |
2021-06-30 | $0.99B | $0.18B | 17.71% |
2021-03-31 | $0.92B | $0.13B | 14.21% |
2020-12-31 | $0.89B | $0.11B | 12.65% |
2020-09-30 | $0.89B | $0.11B | 11.88% |
2020-06-30 | $0.91B | $0.12B | 13.23% |
2020-03-31 | $0.92B | $0.15B | 15.69% |
2019-12-31 | $0.90B | $0.15B | 16.16% |
2019-09-30 | $0.86B | $0.14B | 16.14% |
2019-06-30 | $0.84B | $0.13B | 15.31% |
2019-03-31 | $0.81B | $0.11B | 13.99% |
2018-12-31 | $0.79B | $0.10B | 12.44% |
2018-09-30 | $0.77B | $0.10B | 12.31% |
2018-06-30 | $0.76B | $0.09B | 11.79% |
2018-03-31 | $0.75B | $0.08B | 10.98% |
2017-12-31 | $0.71B | $0.06B | 8.98% |
2017-09-30 | $0.69B | $0.06B | 9.25% |
2017-06-30 | $0.68B | $0.06B | 8.65% |
2017-03-31 | $0.67B | $0.06B | 9.05% |
2016-12-31 | $0.70B | $0.08B | 11.78% |
2016-09-30 | $0.65B | $0.07B | 10.91% |
2016-06-30 | $0.60B | $0.07B | 11.85% |
2016-03-31 | $0.54B | $0.08B | 13.91% |
2015-12-31 | $0.48B | $0.07B | 15.29% |
2015-09-30 | $0.48B | $0.07B | 15.55% |
2015-06-30 | $0.46B | $0.07B | 15.73% |
2015-03-31 | $0.46B | $0.07B | 15.57% |
2014-12-31 | $0.44B | $0.07B | 15.84% |
2014-09-30 | $0.43B | $0.07B | 15.73% |
2014-06-30 | $0.41B | $0.06B | 15.48% |
2014-03-31 | $0.40B | $0.06B | 15.15% |
2013-12-31 | $0.38B | $0.05B | 14.17% |
2013-09-30 | $0.37B | $0.05B | 14.25% |
2013-06-30 | $0.36B | $0.05B | 14.65% |
2013-03-31 | $0.34B | $0.04B | 12.80% |
2012-12-31 | $0.31B | $0.04B | 12.78% |
2012-09-30 | $0.29B | $0.03B | 11.89% |
2012-06-30 | $0.27B | $0.03B | 9.77% |
2012-03-31 | $0.25B | $0.03B | 10.71% |
2011-12-31 | $0.25B | $0.02B | 9.80% |
2011-09-30 | $0.24B | $0.02B | 8.37% |
2011-06-30 | $0.23B | $0.02B | 7.79% |
2011-03-31 | $0.23B | $0.02B | 8.00% |
2010-12-31 | $0.22B | $0.02B | 8.56% |
2010-09-30 | $0.22B | $0.02B | 8.64% |
2010-06-30 | $0.22B | $0.02B | 7.80% |
2010-03-31 | $0.22B | $0.02B | 6.94% |
2009-12-31 | $0.21B | $0.01B | 5.14% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.343B | $1.147B |
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $41.123B | 22.92 |
Inspire Medical Systems (INSP) | United States | $6.468B | 0.00 |
10x Genomics (TXG) | United States | $4.396B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.586B | 0.00 |
Axonics (AXNX) | United States | $3.514B | 0.00 |
Enovis (ENOV) | United States | $3.425B | 26.02 |
Hims & Hers Health (HIMS) | United States | $3.372B | 0.00 |
Azenta (AZTA) | United States | $3.314B | 270.14 |
Olink Holding AB (publ) (OLK) | Sweden | $2.934B | 0.00 |
Privia Health (PRVA) | United States | $2.318B | 102.89 |
Schrodinger (SDGR) | United States | $1.926B | 0.00 |
Phreesia (PHR) | United States | $1.375B | 0.00 |
Definitive Healthcare (DH) | United States | $0.931B | 0.00 |
Standard BioTools (LAB) | United States | $0.780B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
Talkspace (TALK) | United States | $0.603B | 0.00 |
Health Catalyst (HCAT) | United States | $0.436B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.351B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.343B | 0.00 |
P3 Health Partners (PIII) | United States | $0.319B | 0.00 |
American Well (AMWL) | United States | $0.249B | 0.00 |
Butterfly Network (BFLY) | United States | $0.221B | 0.00 |
Augmedix (AUGX) | United States | $0.197B | 0.00 |
TruBridge (TBRG) | United States | $0.139B | 5.97 |
Outset Medical (OM) | United States | $0.111B | 0.00 |
MSP Recovery (LIFW) | United States | $0.097B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.091B | 0.00 |
111 (YI) | China | $0.084B | 0.00 |
Future Health ESG (FHLT) | United States | $0.064B | 0.00 |
Zepp Health (ZEPP) | China | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.041B | 0.00 |
Cue Health (HLTH) | United States | $0.029B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.027B | 0.00 |
Akili (AKLI) | United States | $0.023B | 0.00 |
Movano (MOVE) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
ETAO (ETAO) | United States | $0.020B | 0.00 |
CareCloud (CCLD) | United States | $0.019B | 0.00 |
Centogene (CNTG) | Germany | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.016B | 0.00 |
Syra Health (SYRA) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.011B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Heart Test Laboratories (HSCS) | United States | $0.008B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Motus GI Holdings (MOTS) | United States | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |